295 related articles for article (PubMed ID: 7598277)
1. Comparison of the infusion requirements and recovery profiles of vecuronium and cisatracurium 51W89 in intensive care unit patients.
Prielipp RC; Coursin DB; Scuderi PE; Bowton DL; Ford SR; Cardenas VJ; Vender J; Howard D; Casale EJ; Murray MJ
Anesth Analg; 1995 Jul; 81(1):3-12. PubMed ID: 7598277
[TBL] [Abstract][Full Text] [Related]
2. Randomised controlled trial comparing cisatracurium and vecuronium infusions in a paediatric intensive care unit.
Burmester M; Mok Q
Intensive Care Med; 2005 May; 31(5):686-92. PubMed ID: 15815895
[TBL] [Abstract][Full Text] [Related]
3. The clinical neuromuscular pharmacology of cisatracurium versus vecuronium during outpatient anesthesia.
Stevens JB; Walker SC; Fontenot JP
Anesth Analg; 1997 Dec; 85(6):1278-83. PubMed ID: 9390594
[TBL] [Abstract][Full Text] [Related]
4. Comparison of cisatracurium and vecuronium by infusion in neonates and small infants after congenital heart surgery.
Reich DL; Hollinger I; Harrington DJ; Seiden HS; Chakravorti S; Cook DR
Anesthesiology; 2004 Nov; 101(5):1122-7. PubMed ID: 15505447
[TBL] [Abstract][Full Text] [Related]
5. A comparison of cisatracurium (51W89) and atracurium by infusion in critically ill patients.
Newman PJ; Quinn AC; Grounds RM; Hunter JM; Boyd AH; Eastwood NB; Pollard BJ; Pearson AJ; Harper NJ; Beale RJ; Sutjarittam M; Elliot JM; Bion JF
Crit Care Med; 1997 Jul; 25(7):1139-42. PubMed ID: 9233738
[TBL] [Abstract][Full Text] [Related]
6. The infusion requirements and recovery characteristics of cisatracurium or atracurium in intensive care patients.
Pearson AJ; Harper NJ; Pollard BJ
Intensive Care Med; 1996 Jul; 22(7):694-8. PubMed ID: 8844237
[TBL] [Abstract][Full Text] [Related]
7. A comparison of cisatracurium and atracurium: onset of neuromuscular block after bolus injection and recovery after subsequent infusion.
Mellinghoff H; Radbruch L; Diefenbach C; Buzello W
Anesth Analg; 1996 Nov; 83(5):1072-5. PubMed ID: 8895288
[TBL] [Abstract][Full Text] [Related]
8. Cumulation and reversal with prolonged infusions of atracurium and vecuronium.
Martineau RJ; St-Jean B; Kitts JB; Curran MC; Lindsay P; Hull KA; Miller DR
Can J Anaesth; 1992 Sep; 39(7):670-6. PubMed ID: 1356646
[TBL] [Abstract][Full Text] [Related]
9. Train-of-four fade during onset of neuromuscular block with nondepolarising neuromuscular blocking agents.
Gibson FM; Mirakhur RK
Acta Anaesthesiol Scand; 1989 Apr; 33(3):204-6. PubMed ID: 2567104
[TBL] [Abstract][Full Text] [Related]
10. A prospective, randomized, controlled evaluation of peripheral nerve stimulation versus standard clinical dosing of neuromuscular blocking agents in critically ill patients.
Rudis MI; Sikora CA; Angus E; Peterson E; Popovich J; Hyzy R; Zarowitz BJ
Crit Care Med; 1997 Apr; 25(4):575-83. PubMed ID: 9142020
[TBL] [Abstract][Full Text] [Related]
11. Neuromuscular blocking effects and train-of-four fade with cisatracurium: comparison with other nondepolarising relaxants.
Carroll MT; Mirakhur RK; Lowry DW; McCourt KC; Kerr C
Anaesthesia; 1998 Dec; 53(12):1169-73. PubMed ID: 10193219
[TBL] [Abstract][Full Text] [Related]
12. Comparative pharmacology of cisatracurium (51W89), atracurium, and five isomers in cats.
Wastila WB; Maehr RB; Turner GL; Hill DA; Savarese JJ
Anesthesiology; 1996 Jul; 85(1):169-77. PubMed ID: 8694363
[TBL] [Abstract][Full Text] [Related]
13. Sugammadex reverses neuromuscular block induced by 3-desacetyl-vecuronium, an active metabolite of vecuronium, in the anaesthetised rhesus monkey.
Staals LM; van Egmond J; Driessen JJ; de Boer HD; van de Pol F; Bom AH; Booij LH
Eur J Anaesthesiol; 2011 Apr; 28(4):265-72. PubMed ID: 21157358
[TBL] [Abstract][Full Text] [Related]
14. A two-center study evaluating the hemodynamic and pharmacodynamic effects of cisatracurium and vecuronium in patients undergoing coronary artery bypass surgery.
Searle NR; Thomson I; Dupont C; Cannon JE; Roy M; Rosenbloom M; Gagnon L; Carrier M
J Cardiothorac Vasc Anesth; 1999 Feb; 13(1):20-5. PubMed ID: 10069278
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the pharmacodynamics and pharmacokinetics of an infusion of cis-atracurium (51W89) or atracurium in critically ill patients undergoing mechanical ventilation in an intensive therapy unit.
Boyd AH; Eastwood NB; Parker CJ; Hunter JM
Br J Anaesth; 1996 Mar; 76(3):382-8. PubMed ID: 8785138
[TBL] [Abstract][Full Text] [Related]
16. Neuromuscular interaction between cisatracurium and mivacurium, atracurium, vecuronium or rocuronium administered in combination.
Kim KS; Chun YS; Chon SU; Suh JK
Anaesthesia; 1998 Sep; 53(9):872-8. PubMed ID: 9849281
[TBL] [Abstract][Full Text] [Related]
17. A prospective randomized comparison of train-of-four monitoring and clinical assessment during continuous ICU cisatracurium paralysis.
Baumann MH; McAlpin BW; Brown K; Patel P; Ahmad I; Stewart R; Petrini M
Chest; 2004 Oct; 126(4):1267-73. PubMed ID: 15486392
[TBL] [Abstract][Full Text] [Related]
18. Continuous infusions of atracurium and vecuronium, compared with intermittent boluses of pancuronium: dose requirements and reversal.
Beattie WS; Buckley DN; Forrest JB
Can J Anaesth; 1992 Nov; 39(9):925-31. PubMed ID: 1360337
[TBL] [Abstract][Full Text] [Related]
19. Neuromuscular blocking characteristics of vecuronium after tubocurarine-induced "fade". An experimental double-blind clinical study.
Puura A; Baer GA; Rorarius MG
Eur J Clin Pharmacol; 1999 May; 55(3):173-6. PubMed ID: 10379631
[TBL] [Abstract][Full Text] [Related]
20. Cisatracurium versus vecuronium: a comparative, double blind, randomized, multicenter study in adult patients under propofol/fentanyl/N2O anesthesia.
Melloni C; Devivo P; Launo C; Mastronardi P; Novelli GP; Romano E
Minerva Anestesiol; 2006 May; 72(5):299-308. PubMed ID: 16675938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
